Charles Schwab’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-88,191
Closed -$150K 3173
2017
Q1
$150K Hold
88,191
﹤0.01% 2971
2016
Q4
$186K Hold
88,191
﹤0.01% 2976
2016
Q3
$296K Buy
88,191
+45,000
+104% +$135K ﹤0.01% 2797
2016
Q2
$97K Hold
43,191
﹤0.01% 3059
2016
Q1
$135K Hold
43,191
﹤0.01% 2955
2015
Q4
$122K Hold
43,191
﹤0.01% 3031
2015
Q3
$226K Hold
43,191
﹤0.01% 2927
2015
Q2
$294K Buy
+43,191
New +$306K ﹤0.01% 2886

Other funds holding HLTH

Charles Schwab's HLTH Position: Q2 2017 in Review

Charles Schwab sold out of Nobilis Health Corp. (HLTH) in Q2 2017, closing a stake of 88,191 shares — an estimated $150K sold.

Charles Schwab first reported a position in HLTH in Q2 2015 and held it in 8 quarters. The position peaked at $296K in Q3 2016. 49 funds tracked by Wall St. Rank hold HLTH as of Q2 2017.

  • Charles Schwab reported no remaining Nobilis Health Corp. position as of Q2 2017 after selling out during the quarter.
  • Charles Schwab sold 88,191 Nobilis Health Corp. shares in Q2 2017, an estimated $150K.
  • Charles Schwab first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 8 quarters.
  • Charles Schwab's Nobilis Health Corp. position peaked at $296K in Q3 2016.
  • 49 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q2 2017.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.